483 Biocon Mar 2019

483 Biocon Mar 2019

Jose Cayuela FDA$119.00 - Available Now

FDA investigators audited the Biocon - Bengaluru, India facility and issued inspectional observations (via FDA 483) on 05 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 05 Mar 2019
  • Location: Bengaluru, India
  • FEI: 1000172912
Add To Cart